The Characteristics of Incidental Pituitary Microadenomas in 120 Korean Forensic Autopsy Cases by Kim, Jang-Hee et al.
INTRODUCTION
With technical advances in radiology, incidental pituitary
microadenomas (adenomas less than 10 mm in diameter) are
detected more frequently nowadays. The clinical approach
and treatment of these lesions, however, are controversial
because the majority of lesions are not associated with clini-
cal signs or obvious abnormalities during the subject’s life-
time (1-4). Since the first report of 2 cases of pituitary mic-
roadenomas without clinical manifestations in 1903, several
studies have investigated the incidence and natural history
of these tiny tumors (5-8). However, no previous study of
incidental pituitary microadenomas has been conducted in
Korea. To determine the characteristics of incidental pitu-
itary microadenomas in the Korean population, we investi-
gated pituitary glands obtained from Korean forensic autopsy
cases. 
MATERIALS AND METHODS
Case selection
Five hundred and eighty-five forensic autopsies were per-
formed at the Department of Forensic Medicine, Central
District of the National Institute of Scientific Investigation,
Daejeon, Korea, between March 2003 and February 2004.
From these cases, only 120 pituitary glands were available
for histologic sections because of putrefaction or organ dam-
age from various causes, the subjects being foreigners, or for
other reasons. Each gland was fixed in 10% formalin and cut
in the sagittal plane. Two to five slices (average: four slices)
of the pituitary gland were prepared at 1 to 2 mm intervals,
embedded in paraffin, processed using the standard method,
and stained with hematoxylin and eosin (H&E).
Histological examination
The H&E-stained slides were reviewed, and the diagnosis
of adenoma was made based on the following histologic cri-
teria: a circumscribed group of cells exhibiting cellular uni-
formity, loss of the normal acinar and stromal patterns, and
compression of the adjacent pituitary parenchyma. The pitu-
itary glands that met these criteria were then stained for retic-
ulin to confirm the loss of the stromal pattern and compres-
sion of the adjacent pituitary gland.
Immunohistochemical studies 
The adenomas were stained immunohistochemically using
primary antibodies against the pituitary hormones, prolactin
(PRL) (1:100, Novocastra, Newcastle, U.K.), growth hor-
mone (GH) (1:100, Novocastra), adrenocorticotropic hor-
mone (ACTH) (1:300, DAKO, Glostrup, Denmark), thy-
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To investigate the characteristics of incidental pituitary microadenomas, we exam-
ined 120 pituitary glands from Korean forensic autopsy cases, from which eight
tumors were identified (incidence 6.7%). The average age of the affected subjects
was 50 yr (range: 33-96 yr) with a female predominance. The maximum diameters
of the tumors ranged from 0.4 to 5.4 mm (mean: 2.8 mm). Immunohistochemical
analysis of pituitary hormones revealed three growth hormone-secreting adeno-
mas, one prolactin-producing adenoma, one gonadotropin-producing adenoma,
one plurihormonal adenoma, and two null cell adenomas. MIB-1 staining for Ki-67
antigen showed no positive expression. The microvessel density (MVD) of the pitu-
itary microadenomas ranged from 2.3 to 11.6% (mean: 5.3%) and was significantly
lower than that of nonneoplastic pituitary glands (11.9-20.1%, mean: 14.8%). Our
study provides reference data on incidental pituitary microadenomas in the Kore-
an population. 
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roid-stimulating hormone (TSH) (1:100, Novocastra), lutei-
nizing hormone (LH) (1:500, NeoMarkers, Fremont, CA,
U.S.A.), and follicle-stimulating hormone (FSH) (1:100,
Immunon, Pittsburgh, PA, U.S.A.). To determine the pro-
liferation index, an antibody against MIB-1 (1:100, Zymed,
San Francisco, CA, U.S.A.) was used. An antibody against
CD34 (1:100, Novocastra) was applied to determine the mic-
rovessel density (MVD) using a Lab Vision AutostainerTM
(Lab Vision Co., Fremont, CA, U.S.A.) according to the man-
ufacturer’s instructions. Diaminobenzidine was used as a
chromogen. 
Ki-67 antigen labeling index (LI)
The Ki-67 antigen labeling index (LI) with the MIB-1
antibody was determined manually and expressed as the per-
centage of positive nuclei in at least five fields chosen ran-
domly at ×400 magnification.
Microvessel density (MVD)
MVD was examined semiautomatically with CD34-im-
munostained sections using a computer image analysis sys-
tem (Image Pro Plus; Media Cybernetics, Silver Spring, MD,
U.S.A.). The MVD was calculated by measuring the mean
percentage of the area occupied by vessels in digitally cap-
tured images of microadenomas and nonneoplastic parenchy-
ma under a microscope (BX51; Olympus, Tokyo, Japan) with
a digital camera (DMC2; Polaroid, Cambridge, MA, U.S.A.).
In each case, images were taken from three different areas at
Fig. 1. (A) Pituitary microadenoma (H&E stain, ×100). (B) Loss of
the normal acinar and stromal patterns and compression of the
adjacent pituitary parenchyma (reticulin stain, ×100). (C) Positive
immunoreactivity with prolactin (×100). 
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×200 magnification. The paired t-test was used to deter-
mine the difference in the MVD between microadenomas
and non-neoplastic parenchyma using the SPSS software
package (SPSS Inc., Chicago, IL, U.S.A.).
RESULTS
Of the 120 pituitary glands, 61 glands were from males
and 59 were from females. The age distribution ranged from
neonates to 96 yr (0 to 10 yr, n=13; 11 to 20 yr, n=11; 21
to 30 yr, n=22; 31 to 40 yr, n=19; 41 to 50 yr, n=20; 51 to
60 yr, n=13; 61 to 70 yr, n=16; 71 to 96 yr, n=6). The cause
of death varied and included natural diseases such as ischemic
heart disease and unnatural causes such as hanging, drown-
ing, and multiple injuries. Two cases had diabetes, while the
remainder had no medical history of endocrine disorders. Nine
lesions in eight pituitary glands were suspected of being mic-
roadenomas based on H&E staining (Fig. 1A), and eight mic-
roadenomas were confirmed in seven pituitary glands with
reticulin stain (Fig. 1B) (incidence 6.7%). One case was hyper-
plasia, six cases were single microadenomas, and the remain-
ing two pituitary microadenomas were contained in one gland.
Five of them were in females and three were in two males.
Their ages ranged from 33 to 96 yr and averaged 50 yr. The
maximum diameter of the tumors ranged from 0.4 to 5.4 mm
(mean: 2.8 mm).
Three of the eight microadenomas were diffusely positive
for GH (37.5%), one was diffusely positive for PRL (12.5%),
one was diffusely positive for PRL, GH, and TSH (12.5%),
and one was diffusely positive for FSH and focally positive
for LH (12.5%). The two adenomas found in one pituitary
gland (Case 5) showed different immunoreactivities: one was
diffusely positive for GH and the other was diffusely positive
Case 
No.
Age (yr)/
Sex
Cause
of death
LH FSH TSH ACTH GH PRL
Maximum 
diameter of the
tumor (mm)
MVD (%)
MA NP
1 33/F HCM 1.8 + 3.7 15.5
2 38/M SCD 5.4 + 7.6 14.7
3 38/F Trauma 4.8 + 2.3 11.9
4 40/F SCD 4.6 3.4 16.9
5 52/M IHD 1.3 + + + 11.6 12.3
0.9 + 6.1 12.3
6 56/F Intoxication 0.4 4.0 20.1
7 96/F Trauma 2.8 + + (focal) 3.9 14.8
Table 1. The characteristics of incidental pituitary microadenomas
PRL, prolactin; GH, growth hormone; ACTH, adrenocorticotropic hormone; TSH, thyroid-stimulating hormone; FSH, follicle-stimulating hormone; LH,
luteinizing hormone; MVD, microvessel density; MA, microadenoma; NP, non-neoplastic pituitary gland; HCM, hypertrophic cardiomyopathy; SCD,
sudden cardiac death; IHD, ischemic heart disease.
Fig. 2. Microvessel density measurement using an image analy-
zer with CD 34 immunostain (×200). 
Fig. 3. Microvessel density in microadenomas and non-neoplas-
tic pituitary gland showing a significant difference.
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for PRL, GH, and TSH (Table 1, Fig. 1C). The remaining
two adenomas were negative for all hormones (25.0%). The
Ki-67 LI could not be determined because no microadeno-
mas expressed MIB-1. 
The MVD of the pituitary microadenomas ranged from
2.3 to 11.6% (mean: 5.3%; Table 1, Fig. 2) and was signifi-
cantly different from that of non-neoplastic pituitary glands
(11.9-20.1%, mean: 14.8%; p<0.001; Fig. 3). 
DISCUSSION
Pituitary microadenomas were detected using computed
tomography (CT) or magnetic resonance imaging (MRI) scan
in between 3.7% and 37.0% of cases (2, 9), while autopsy
studies revealed a prevalence ranging from 1.4 to 27.0% (6,
8). This wide variation might be due to the histological cri-
teria and sectioning methods. Some earlier studies used cel-
lular uniformity and loss of the normal stromal pattern as
the only criteria for microadenoma, resulting in a relatively
high incidence of pituitary microadenoma (10, 11). Conver-
sely, the reticulin stains, which we used in this study, have
rarely been used to confirm the diagnosis of pituitary mic-
roadenomas (6, 12). Although the number and thickness of
tissue sections might result in different percentages of inci-
dental microadenomas (8, 10), their correlation remains con-
troversial (6, 7, 12). It was reported that there was no rela-
tionship between the size of the series involved and the num-
ber of adenomas detected (6). In our study, the incidence of
pituitary microadenomas (6.7%) was relatively low. One pos-
sible explanation might be the larger proportion of younger
subjects in our series. Those series that included children in
their patient group reported relatively low incidences of pitu-
itary microadenomas, which could be due to the low preva-
lence of pituitary adenomas in the pediatric population (7,
13, 14). In our study, the incidence of pituitary microade-
nomas was higher (10.8%) when the subjects under 30 yr
of age were excluded. The female predominance in our study
differs from previous autopsy studies that showed no sex
predominance (6, 8, 12) or a slight male predominance (7).
However, clinical studies based on radiology, laboratory find-
ings, and surgery show a slight female predominance, simi-
lar to our results (3, 9, 15).
In our study, the two most common types of adenoma were
GH-positive adenoma (37.5%) and null cell adenoma (25.0
%). Immunohistochemical staining for prolactin was positive
in two microadenomas, and only one adenoma was a prolac-
tinoma (12.5%). These results are inconsistent with previ-
ous studies in which the reported frequency of prolactinoma
was as high as 53.0% (6-8, 13, 16). Interestingly, one microa-
denoma from a very old woman (Case No. 7) was FSH-posi-
tive with focal scattered LH positivity. It is quite possible
that the age-related decline in sex hormone levels and sub-
sequent stimulation of gonadotrophs are related to the devel-
opment of pituitary tumors (13). 
The Ki-67 LI with MIB-1 antibody for pituitary adeno-
ma is relatively low compared to other brain tumors, and a
Ki-67 LI greater than 3.0% has been suggested as a useful
marker of aggressive behaviors, such as recurrence and inva-
sive growth (17). Few studies have determined the Ki-67 LI
of pituitary microadenomas even with surgical specimens,
and the reported LI of microadenomas ranges from 1.1 to
1.8% (18, 19). A correlation between the Ki-67 LI and the
maximum tumor diameter has been suggested, and certain
types of microadenoma have a high proliferation index (20).
No MIB-1 expression was found in our study, perhaps because
the tissues were obtained at autopsy, not from surgical spec-
imens. Nevertheless, possible technical errors during immu-
nohistochemical staining cannot be ruled out, because repeat-
ed examination was not possible due to tumor loss after using
several sections for immunohistochemical and reticulin stain-
ing.
Angiogenesis characterized by a high MVD is essential for
tumor growth and metastasis. In contrast to the majority of
solid tumors, pituitary adenomas show decreased expression
of vascular endothelial growth factor and have significantly
lower microvessel densities compared to non-neoplastic pitu-
itary glands (18, 21). Our results are in good agreement with
these studies, and suggest that angiogenic inhibitors may
play a role in the behavior of these tumors (21, 22). This dif-
ference in MVD between adenoma and non-neoplastic pitu-
itary gland could be a useful method to discriminate microa-
denomas from non-neoplastic pituitary gland in surgical spe-
cimens. In our study, a variation in the MVD according to
the type of pituitary adenoma was noted. Similar to previous
studies (21, 22), prolactinomas had a relatively lower MVD
than other types of adenoma. Although a significantly lower
vascularity of microprolactinomas has been suggested than
that of macroprolactinomas (22), no significant difference in
MVD was observed between microadenomas and macroade-
nomas in adult patients (24).
In conclusion, our study determined the incidence and
characteristics of incidental pituitary microadenomas in
autopsy cases from the Korean population. Although our
study examined a Korean forensic population, it neverthe-
less provides a valuable reference on incidental pituitary
microadenomas in the general Korean population.
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